Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SH2 domain-containing protein 4B (SH2D4B) is a member of the family of proteins characterized by the presence of an Src homology 2 (SH2) domain—a structurally conserved motif of about 100 amino acids that mediates specific binding to phosphorylated tyrosine residues on other proteins[3][1]. SH2D4B is classified as an adaptor protein, meaning it primarily facilitates protein-protein interactions in intracellular signaling, rather than performing enzymatic or receptor functions itself[1]. It shares this classification with other SH2 domain-containing proteins that participate broadly in organizing and propagating intracellular signal transduction networks, especially those downstream of receptor tyrosine kinases[3][1]. There is no evidence that SH2D4B is currently a direct therapeutic target or has established roles in specific diseases or as a biomarker. Its tissue expression, according to The Human Protein Atlas, is detected in multiple tissues, suggesting a general role in cell signaling[2][4]. No drugs or targeted interventions are reported to interact with SH2D4B, nor are there known mechanisms of drug action specifically involving this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SH2 domain-containing protein 4B (SH2D4B).